Molecular diagnosis of tumor refers to the molecular biological diagnosis technology with nucleic acid or protein as the core, which is an important method for early diagnosis of tumor.

The global Oncology Based Molecular Diagnostics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Oncology Based Molecular Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oncology Based Molecular Diagnostics.

Report Scope

The Oncology Based Molecular Diagnostics market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oncology Based Molecular Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Oncology Based Molecular Diagnostics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Oncology Based Molecular Diagnostics Market Report

Report Metric	Details
Report Name	Oncology Based Molecular Diagnostics Market
CAGR	5%
Segment by Type	PCR Multiplex PCR In Situ Hybridization Isothermal Nucleic Acid Amplification Technology (INAAT)
Segment by Application	Breast Cancer Prostate Cancer Colorectal Cancer Cervical Cancer Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Abbott Laboratories, Bayer Healthcare, Becton Dickinson, Cepheid, Dako, Danaher Corporation, Gen Probe(Hologic), Roche Diagnostics, Siemens Healthcare
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Oncology Based Molecular Diagnostics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Oncology Based Molecular Diagnostics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Oncology Based Molecular Diagnostics Market report?

Ans: The main players in the Oncology Based Molecular Diagnostics Market are Abbott Laboratories, Bayer Healthcare, Becton Dickinson, Cepheid, Dako, Danaher Corporation, Gen Probe(Hologic), Roche Diagnostics, Siemens Healthcare

What are the Application segmentation covered in the Oncology Based Molecular Diagnostics Market report?

Ans: The Applications covered in the Oncology Based Molecular Diagnostics Market report are Breast Cancer, Prostate Cancer, Colorectal Cancer, Cervical Cancer, Other

What are the Type segmentation covered in the Oncology Based Molecular Diagnostics Market report?

Ans: The Types covered in the Oncology Based Molecular Diagnostics Market report are PCR, Multiplex PCR, In Situ Hybridization, Isothermal Nucleic Acid Amplification Technology (INAAT)

1 Oncology Based Molecular Diagnostics Market Overview

1.1 Product Overview and Scope of Oncology Based Molecular Diagnostics

1.2 Oncology Based Molecular Diagnostics Segment by Type

1.2.1 Global Oncology Based Molecular Diagnostics Market Value Comparison by Type (2024-2030)

1.2.2 PCR

1.2.3 Multiplex PCR

1.2.4 In Situ Hybridization

1.2.5 Isothermal Nucleic Acid Amplification Technology (INAAT)

1.3 Oncology Based Molecular Diagnostics Segment by Application

1.3.1 Global Oncology Based Molecular Diagnostics Market Value by Application: (2024-2030)

1.3.2 Breast Cancer

1.3.3 Prostate Cancer

1.3.4 Colorectal Cancer

1.3.5 Cervical Cancer

1.3.6 Other

1.4 Global Oncology Based Molecular Diagnostics Market Size Estimates and Forecasts

1.4.1 Global Oncology Based Molecular Diagnostics Revenue 2019-2030

1.4.2 Global Oncology Based Molecular Diagnostics Sales 2019-2030

1.4.3 Global Oncology Based Molecular Diagnostics Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Oncology Based Molecular Diagnostics Market Competition by Manufacturers

2.1 Global Oncology Based Molecular Diagnostics Sales Market Share by Manufacturers (2019-2024)

2.2 Global Oncology Based Molecular Diagnostics Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Oncology Based Molecular Diagnostics Average Price by Manufacturers (2019-2024)

2.4 Global Oncology Based Molecular Diagnostics Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Oncology Based Molecular Diagnostics, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Oncology Based Molecular Diagnostics, Product Type & Application

2.7 Oncology Based Molecular Diagnostics Market Competitive Situation and Trends

2.7.1 Oncology Based Molecular Diagnostics Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Oncology Based Molecular Diagnostics Players Market Share by Revenue

2.7.3 Global Oncology Based Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Oncology Based Molecular Diagnostics Retrospective Market Scenario by Region

3.1 Global Oncology Based Molecular Diagnostics Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Oncology Based Molecular Diagnostics Global Oncology Based Molecular Diagnostics Sales by Region: 2019-2030

3.2.1 Global Oncology Based Molecular Diagnostics Sales by Region: 2019-2024

3.2.2 Global Oncology Based Molecular Diagnostics Sales by Region: 2025-2030

3.3 Global Oncology Based Molecular Diagnostics Global Oncology Based Molecular Diagnostics Revenue by Region: 2019-2030

3.3.1 Global Oncology Based Molecular Diagnostics Revenue by Region: 2019-2024

3.3.2 Global Oncology Based Molecular Diagnostics Revenue by Region: 2025-2030

3.4 North America Oncology Based Molecular Diagnostics Market Facts & Figures by Country

3.4.1 North America Oncology Based Molecular Diagnostics Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Oncology Based Molecular Diagnostics Sales by Country (2019-2030)

3.4.3 North America Oncology Based Molecular Diagnostics Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Oncology Based Molecular Diagnostics Market Facts & Figures by Country

3.5.1 Europe Oncology Based Molecular Diagnostics Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Oncology Based Molecular Diagnostics Sales by Country (2019-2030)

3.5.3 Europe Oncology Based Molecular Diagnostics Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Oncology Based Molecular Diagnostics Market Facts & Figures by Country

3.6.1 Asia Pacific Oncology Based Molecular Diagnostics Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Oncology Based Molecular Diagnostics Sales by Country (2019-2030)

3.6.3 Asia Pacific Oncology Based Molecular Diagnostics Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Oncology Based Molecular Diagnostics Market Facts & Figures by Country

3.7.1 Latin America Oncology Based Molecular Diagnostics Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Oncology Based Molecular Diagnostics Sales by Country (2019-2030)

3.7.3 Latin America Oncology Based Molecular Diagnostics Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Oncology Based Molecular Diagnostics Market Facts & Figures by Country

3.8.1 Middle East and Africa Oncology Based Molecular Diagnostics Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Oncology Based Molecular Diagnostics Sales by Country (2019-2030)

3.8.3 Middle East and Africa Oncology Based Molecular Diagnostics Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Oncology Based Molecular Diagnostics Sales by Type (2019-2030)

4.1.1 Global Oncology Based Molecular Diagnostics Sales by Type (2019-2024)

4.1.2 Global Oncology Based Molecular Diagnostics Sales by Type (2025-2030)

4.1.3 Global Oncology Based Molecular Diagnostics Sales Market Share by Type (2019-2030)

4.2 Global Oncology Based Molecular Diagnostics Revenue by Type (2019-2030)

4.2.1 Global Oncology Based Molecular Diagnostics Revenue by Type (2019-2024)

4.2.2 Global Oncology Based Molecular Diagnostics Revenue by Type (2025-2030)

4.2.3 Global Oncology Based Molecular Diagnostics Revenue Market Share by Type (2019-2030)

4.3 Global Oncology Based Molecular Diagnostics Price by Type (2019-2030)

5 Segment by Application

5.1 Global Oncology Based Molecular Diagnostics Sales by Application (2019-2030)

5.1.1 Global Oncology Based Molecular Diagnostics Sales by Application (2019-2024)

5.1.2 Global Oncology Based Molecular Diagnostics Sales by Application (2025-2030)

5.1.3 Global Oncology Based Molecular Diagnostics Sales Market Share by Application (2019-2030)

5.2 Global Oncology Based Molecular Diagnostics Revenue by Application (2019-2030)

5.2.1 Global Oncology Based Molecular Diagnostics Revenue by Application (2019-2024)

5.2.2 Global Oncology Based Molecular Diagnostics Revenue by Application (2025-2030)

5.2.3 Global Oncology Based Molecular Diagnostics Revenue Market Share by Application (2019-2030)

5.3 Global Oncology Based Molecular Diagnostics Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Abbott Laboratories

6.1.1 Abbott Laboratories Corporation Information

6.1.2 Abbott Laboratories Description and Business Overview

6.1.3 Abbott Laboratories Oncology Based Molecular Diagnostics Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Abbott Laboratories Oncology Based Molecular Diagnostics Product Portfolio

6.1.5 Abbott Laboratories Recent Developments/Updates

6.2 Bayer Healthcare

6.2.1 Bayer Healthcare Corporation Information

6.2.2 Bayer Healthcare Description and Business Overview

6.2.3 Bayer Healthcare Oncology Based Molecular Diagnostics Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Bayer Healthcare Oncology Based Molecular Diagnostics Product Portfolio

6.2.5 Bayer Healthcare Recent Developments/Updates

6.3 Becton Dickinson

6.3.1 Becton Dickinson Corporation Information

6.3.2 Becton Dickinson Description and Business Overview

6.3.3 Becton Dickinson Oncology Based Molecular Diagnostics Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Becton Dickinson Oncology Based Molecular Diagnostics Product Portfolio

6.3.5 Becton Dickinson Recent Developments/Updates

6.4 Cepheid

6.4.1 Cepheid Corporation Information

6.4.2 Cepheid Description and Business Overview

6.4.3 Cepheid Oncology Based Molecular Diagnostics Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Cepheid Oncology Based Molecular Diagnostics Product Portfolio

6.4.5 Cepheid Recent Developments/Updates

6.5 Dako

6.5.1 Dako Corporation Information

6.5.2 Dako Description and Business Overview

6.5.3 Dako Oncology Based Molecular Diagnostics Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Dako Oncology Based Molecular Diagnostics Product Portfolio

6.5.5 Dako Recent Developments/Updates

6.6 Danaher Corporation

6.6.1 Danaher Corporation Corporation Information

6.6.2 Danaher Corporation Description and Business Overview

6.6.3 Danaher Corporation Oncology Based Molecular Diagnostics Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Danaher Corporation Oncology Based Molecular Diagnostics Product Portfolio

6.6.5 Danaher Corporation Recent Developments/Updates

6.7 Gen Probe(Hologic)

6.6.1 Gen Probe(Hologic) Corporation Information

6.6.2 Gen Probe(Hologic) Description and Business Overview

6.6.3 Gen Probe(Hologic) Oncology Based Molecular Diagnostics Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Gen Probe(Hologic) Oncology Based Molecular Diagnostics Product Portfolio

6.7.5 Gen Probe(Hologic) Recent Developments/Updates

6.8 Roche Diagnostics

6.8.1 Roche Diagnostics Corporation Information

6.8.2 Roche Diagnostics Description and Business Overview

6.8.3 Roche Diagnostics Oncology Based Molecular Diagnostics Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Roche Diagnostics Oncology Based Molecular Diagnostics Product Portfolio

6.8.5 Roche Diagnostics Recent Developments/Updates

6.9 Siemens Healthcare

6.9.1 Siemens Healthcare Corporation Information

6.9.2 Siemens Healthcare Description and Business Overview

6.9.3 Siemens Healthcare Oncology Based Molecular Diagnostics Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Siemens Healthcare Oncology Based Molecular Diagnostics Product Portfolio

6.9.5 Siemens Healthcare Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Oncology Based Molecular Diagnostics Industry Chain Analysis

7.2 Oncology Based Molecular Diagnostics Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Oncology Based Molecular Diagnostics Production Mode & Process

7.4 Oncology Based Molecular Diagnostics Sales and Marketing

7.4.1 Oncology Based Molecular Diagnostics Sales Channels

7.4.2 Oncology Based Molecular Diagnostics Distributors

7.5 Oncology Based Molecular Diagnostics Customers

8 Oncology Based Molecular Diagnostics Market Dynamics

8.1 Oncology Based Molecular Diagnostics Industry Trends

8.2 Oncology Based Molecular Diagnostics Market Drivers

8.3 Oncology Based Molecular Diagnostics Market Challenges

8.4 Oncology Based Molecular Diagnostics Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Oncology Based Molecular Diagnostics Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Oncology Based Molecular Diagnostics Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Oncology Based Molecular Diagnostics Market Competitive Situation by Manufacturers in 2023

Table 4. Global Oncology Based Molecular Diagnostics Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Oncology Based Molecular Diagnostics Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Oncology Based Molecular Diagnostics Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Oncology Based Molecular Diagnostics Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Oncology Based Molecular Diagnostics Average Price (USD/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Oncology Based Molecular Diagnostics, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Oncology Based Molecular Diagnostics, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Oncology Based Molecular Diagnostics, Product Type & Application

Table 12. Global Key Manufacturers of Oncology Based Molecular Diagnostics, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Oncology Based Molecular Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Based Molecular Diagnostics as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Oncology Based Molecular Diagnostics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Oncology Based Molecular Diagnostics Sales by Region (2019-2024) & (K Units)

Table 18. Global Oncology Based Molecular Diagnostics Sales Market Share by Region (2019-2024)

Table 19. Global Oncology Based Molecular Diagnostics Sales by Region (2025-2030) & (K Units)

Table 20. Global Oncology Based Molecular Diagnostics Sales Market Share by Region (2025-2030)

Table 21. Global Oncology Based Molecular Diagnostics Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Oncology Based Molecular Diagnostics Revenue Market Share by Region (2019-2024)

Table 23. Global Oncology Based Molecular Diagnostics Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Oncology Based Molecular Diagnostics Revenue Market Share by Region (2025-2030)

Table 25. North America Oncology Based Molecular Diagnostics Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Oncology Based Molecular Diagnostics Sales by Country (2019-2024) & (K Units)

Table 27. North America Oncology Based Molecular Diagnostics Sales by Country (2025-2030) & (K Units)

Table 28. North America Oncology Based Molecular Diagnostics Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Oncology Based Molecular Diagnostics Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Oncology Based Molecular Diagnostics Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Oncology Based Molecular Diagnostics Sales by Country (2019-2024) & (K Units)

Table 32. Europe Oncology Based Molecular Diagnostics Sales by Country (2025-2030) & (K Units)

Table 33. Europe Oncology Based Molecular Diagnostics Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Oncology Based Molecular Diagnostics Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Oncology Based Molecular Diagnostics Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Oncology Based Molecular Diagnostics Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Oncology Based Molecular Diagnostics Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Oncology Based Molecular Diagnostics Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Oncology Based Molecular Diagnostics Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Oncology Based Molecular Diagnostics Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Oncology Based Molecular Diagnostics Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Oncology Based Molecular Diagnostics Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Oncology Based Molecular Diagnostics Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Oncology Based Molecular Diagnostics Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Oncology Based Molecular Diagnostics Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Oncology Based Molecular Diagnostics Sales by Country (2019-2024) & (K Units)

Table 47. Middle East & Africa Oncology Based Molecular Diagnostics Sales by Country (2025-2030) & (K Units)

Table 48. Middle East & Africa Oncology Based Molecular Diagnostics Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Oncology Based Molecular Diagnostics Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Oncology Based Molecular Diagnostics Sales (K Units) by Type (2019-2024)

Table 51. Global Oncology Based Molecular Diagnostics Sales (K Units) by Type (2025-2030)

Table 52. Global Oncology Based Molecular Diagnostics Sales Market Share by Type (2019-2024)

Table 53. Global Oncology Based Molecular Diagnostics Sales Market Share by Type (2025-2030)

Table 54. Global Oncology Based Molecular Diagnostics Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Oncology Based Molecular Diagnostics Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Oncology Based Molecular Diagnostics Revenue Market Share by Type (2019-2024)

Table 57. Global Oncology Based Molecular Diagnostics Revenue Market Share by Type (2025-2030)

Table 58. Global Oncology Based Molecular Diagnostics Price (USD/Unit) by Type (2019-2024)

Table 59. Global Oncology Based Molecular Diagnostics Price (USD/Unit) by Type (2025-2030)

Table 60. Global Oncology Based Molecular Diagnostics Sales (K Units) by Application (2019-2024)

Table 61. Global Oncology Based Molecular Diagnostics Sales (K Units) by Application (2025-2030)

Table 62. Global Oncology Based Molecular Diagnostics Sales Market Share by Application (2019-2024)

Table 63. Global Oncology Based Molecular Diagnostics Sales Market Share by Application (2025-2030)

Table 64. Global Oncology Based Molecular Diagnostics Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Oncology Based Molecular Diagnostics Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Oncology Based Molecular Diagnostics Revenue Market Share by Application (2019-2024)

Table 67. Global Oncology Based Molecular Diagnostics Revenue Market Share by Application (2025-2030)

Table 68. Global Oncology Based Molecular Diagnostics Price (USD/Unit) by Application (2019-2024)

Table 69. Global Oncology Based Molecular Diagnostics Price (USD/Unit) by Application (2025-2030)

Table 70. Abbott Laboratories Corporation Information

Table 71. Abbott Laboratories Description and Business Overview

Table 72. Abbott Laboratories Oncology Based Molecular Diagnostics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 73. Abbott Laboratories Oncology Based Molecular Diagnostics Product

Table 74. Abbott Laboratories Recent Developments/Updates

Table 75. Bayer Healthcare Corporation Information

Table 76. Bayer Healthcare Description and Business Overview

Table 77. Bayer Healthcare Oncology Based Molecular Diagnostics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 78. Bayer Healthcare Oncology Based Molecular Diagnostics Product

Table 79. Bayer Healthcare Recent Developments/Updates

Table 80. Becton Dickinson Corporation Information

Table 81. Becton Dickinson Description and Business Overview

Table 82. Becton Dickinson Oncology Based Molecular Diagnostics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 83. Becton Dickinson Oncology Based Molecular Diagnostics Product

Table 84. Becton Dickinson Recent Developments/Updates

Table 85. Cepheid Corporation Information

Table 86. Cepheid Description and Business Overview

Table 87. Cepheid Oncology Based Molecular Diagnostics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 88. Cepheid Oncology Based Molecular Diagnostics Product

Table 89. Cepheid Recent Developments/Updates

Table 90. Dako Corporation Information

Table 91. Dako Description and Business Overview

Table 92. Dako Oncology Based Molecular Diagnostics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 93. Dako Oncology Based Molecular Diagnostics Product

Table 94. Dako Recent Developments/Updates

Table 95. Danaher Corporation Corporation Information

Table 96. Danaher Corporation Description and Business Overview

Table 97. Danaher Corporation Oncology Based Molecular Diagnostics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 98. Danaher Corporation Oncology Based Molecular Diagnostics Product

Table 99. Danaher Corporation Recent Developments/Updates

Table 100. Gen Probe(Hologic) Corporation Information

Table 101. Gen Probe(Hologic) Description and Business Overview

Table 102. Gen Probe(Hologic) Oncology Based Molecular Diagnostics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 103. Gen Probe(Hologic) Oncology Based Molecular Diagnostics Product

Table 104. Gen Probe(Hologic) Recent Developments/Updates

Table 105. Roche Diagnostics Corporation Information

Table 106. Roche Diagnostics Description and Business Overview

Table 107. Roche Diagnostics Oncology Based Molecular Diagnostics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 108. Roche Diagnostics Oncology Based Molecular Diagnostics Product

Table 109. Roche Diagnostics Recent Developments/Updates

Table 110. Siemens Healthcare Corporation Information

Table 111. Siemens Healthcare Description and Business Overview

Table 112. Siemens Healthcare Oncology Based Molecular Diagnostics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 113. Siemens Healthcare Oncology Based Molecular Diagnostics Product

Table 114. Siemens Healthcare Recent Developments/Updates

Table 115. Key Raw Materials Lists

Table 116. Raw Materials Key Suppliers Lists

Table 117. Oncology Based Molecular Diagnostics Distributors List

Table 118. Oncology Based Molecular Diagnostics Customers List

Table 119. Oncology Based Molecular Diagnostics Market Trends

Table 120. Oncology Based Molecular Diagnostics Market Drivers

Table 121. Oncology Based Molecular Diagnostics Market Challenges

Table 122. Oncology Based Molecular Diagnostics Market Restraints

Table 123. Research Programs/Design for This Report

Table 124. Key Data Information from Secondary Sources

Table 125. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Oncology Based Molecular Diagnostics

Figure 2. Global Oncology Based Molecular Diagnostics Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Oncology Based Molecular Diagnostics Market Share by Type in 2023 & 2030

Figure 4. PCR Product Picture

Figure 5. Multiplex PCR Product Picture

Figure 6. In Situ Hybridization Product Picture

Figure 7. Isothermal Nucleic Acid Amplification Technology (INAAT) Product Picture

Figure 8. Global Oncology Based Molecular Diagnostics Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 9. Global Oncology Based Molecular Diagnostics Market Share by Application in 2023 & 2030

Figure 10. Breast Cancer

Figure 11. Prostate Cancer

Figure 12. Colorectal Cancer

Figure 13. Cervical Cancer

Figure 14. Other

Figure 15. Global Oncology Based Molecular Diagnostics Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 16. Global Oncology Based Molecular Diagnostics Market Size (2019-2030) & (US$ Million)

Figure 17. Global Oncology Based Molecular Diagnostics Sales (2019-2030) & (K Units)

Figure 18. Global Oncology Based Molecular Diagnostics Average Price (USD/Unit) & (2019-2030)

Figure 19. Oncology Based Molecular Diagnostics Report Years Considered

Figure 20. Oncology Based Molecular Diagnostics Sales Share by Manufacturers in 2023

Figure 21. Global Oncology Based Molecular Diagnostics Revenue Share by Manufacturers in 2023

Figure 22. The Global 5 and 10 Largest Oncology Based Molecular Diagnostics Players: Market Share by Revenue in 2023

Figure 23. Oncology Based Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 24. Global Oncology Based Molecular Diagnostics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 25. North America Oncology Based Molecular Diagnostics Sales Market Share by Country (2019-2030)

Figure 26. North America Oncology Based Molecular Diagnostics Revenue Market Share by Country (2019-2030)

Figure 27. U.S. Oncology Based Molecular Diagnostics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. Canada Oncology Based Molecular Diagnostics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. Europe Oncology Based Molecular Diagnostics Sales Market Share by Country (2019-2030)

Figure 30. Europe Oncology Based Molecular Diagnostics Revenue Market Share by Country (2019-2030)

Figure 31. Germany Oncology Based Molecular Diagnostics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. France Oncology Based Molecular Diagnostics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. U.K. Oncology Based Molecular Diagnostics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. Italy Oncology Based Molecular Diagnostics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. Russia Oncology Based Molecular Diagnostics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. Asia Pacific Oncology Based Molecular Diagnostics Sales Market Share by Region (2019-2030)

Figure 37. Asia Pacific Oncology Based Molecular Diagnostics Revenue Market Share by Region (2019-2030)

Figure 38. China Oncology Based Molecular Diagnostics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. Japan Oncology Based Molecular Diagnostics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. South Korea Oncology Based Molecular Diagnostics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. India Oncology Based Molecular Diagnostics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Australia Oncology Based Molecular Diagnostics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Taiwan Oncology Based Molecular Diagnostics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Indonesia Oncology Based Molecular Diagnostics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Thailand Oncology Based Molecular Diagnostics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Malaysia Oncology Based Molecular Diagnostics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Philippines Oncology Based Molecular Diagnostics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Latin America Oncology Based Molecular Diagnostics Sales Market Share by Country (2019-2030)

Figure 49. Latin America Oncology Based Molecular Diagnostics Revenue Market Share by Country (2019-2030)

Figure 50. Mexico Oncology Based Molecular Diagnostics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Brazil Oncology Based Molecular Diagnostics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. Argentina Oncology Based Molecular Diagnostics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 53. Middle East & Africa Oncology Based Molecular Diagnostics Sales Market Share by Country (2019-2030)

Figure 54. Middle East & Africa Oncology Based Molecular Diagnostics Revenue Market Share by Country (2019-2030)

Figure 55. Turkey Oncology Based Molecular Diagnostics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 56. Saudi Arabia Oncology Based Molecular Diagnostics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 57. U.A.E Oncology Based Molecular Diagnostics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 58. Global Sales Market Share of Oncology Based Molecular Diagnostics by Type (2019-2030)

Figure 59. Global Revenue Market Share of Oncology Based Molecular Diagnostics by Type (2019-2030)

Figure 60. Global Oncology Based Molecular Diagnostics Price (USD/Unit) by Type (2019-2030)

Figure 61. Global Sales Market Share of Oncology Based Molecular Diagnostics by Application (2019-2030)

Figure 62. Global Revenue Market Share of Oncology Based Molecular Diagnostics by Application (2019-2030)

Figure 63. Global Oncology Based Molecular Diagnostics Price (USD/Unit) by Application (2019-2030)

Figure 64. Oncology Based Molecular Diagnostics Value Chain

Figure 65. Oncology Based Molecular Diagnostics Production Process

Figure 66. Channels of Distribution (Direct Vs Distribution)

Figure 67. Distributors Profiles

Figure 68. Bottom-up and Top-down Approaches for This Report

Figure 69. Data Triangulation

Figure 70. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Colon Cancer Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-31C5944

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global CAR T-Cell Immunotherapy Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-10J13802

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Color Detection Sensors Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-6G9623

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Appendix Cancer Treatment Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-2H1312

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions